Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 Dear Sir / Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 13th August, 2022) which commenced at 03:30 P.M. and concluded at 05:00 P.M. have inter alia approved the following: ? The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter ended 31st December, 2022 alongwith Limited Review Report duly signed by the Auditors of the company. Kindly take on record the same and oblige. Thanking You.
13-02-2023
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Corrigendum to Detailed Public Statement

 Navigant Corporate Advisors Ltd ("Manager to the Offer") has submitted to BSE a copy of Corrigendum to the detailed Public Statement to the Shareholders of Prism Medico and Pharmacy Ltd ("Target Company").
09-02-2023
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Letter of Offer

 Navigant Corporate Advisors Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Equity Shareholders of Prism Medico and Pharmacy Ltd ("Target Company").
09-02-2023
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Board Meeting Intimation for Intimation Of Board Meeting.

 PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 ,inter alia, to consider and approve Dear Sir / Madam, With reference to the captioned subject and in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the meeting of the Board of Directors of M/s. Prism Medico and Pharmacy Limited (hereinafter referred as 'the Company') is scheduled to be held at the registered office of the company i.e. Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh-173030 on Monday, the 13th day of February, 2023 at 03:30 P.M. inter alia, to: - Consider, approve and take on record the Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter ended 31st December, 2022, as per Regulation 33 of the Listing Regulations. - Consider and discuss any other routine matter or business of the company. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You.
03-02-2023
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Undertaking Of Functional Website.

 Dear Sir / Madam, This is to inform you that the website of M/s. Prism Medico and Pharmacy Limited is updated and functional as per Regulation 46 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The website address of the company is https://www.prismmedico.in. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You.
28-01-2023
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Non-Applicability Of Regulation 27 On Corporate Governance Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended 31St December, 2022.

 Dear Sir / Madam, With reference to the above captioned subject it is hereby informed that the provisions of Regulation 27 on Corporate Governance of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 are not applicable on the company for the quarter ended 31st December, 2022. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You.
23-01-2023
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.

 Dear Sir / Madam, With reference to the above captioned subject report on investor complaints for the quarter ended 31st December, 2022 is attached herewith. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You.
16-01-2023
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Dear Sir/Madam, Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 we hereby furnish a copy of compliance certificate issued by the RTA for the quarter ended 31st December, 2022. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You.
14-01-2023
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Closure of Trading Window

 Pursuant to Code of Conduct to regulate, monitor and report Trading by Insiders ('Code') and applicable SEBI Regulations, we would like to inform you that trading window for dealing in securities of the company by insiders stands closed from January 01, 2023 and will be re-opened 48 hours after the declaration of the financial results for the quarter ended December 31, 2022 to the Stock Exchanges.
02-01-2023
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Draft Letter of Offer

 Navigant Corporate Advisors Ltd ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer for the attention of the Equity Shareholders of Prism Medico and Pharmacy Ltd ("Target Company").
12-12-2022
Next Page
Close

Let's Open Free Demat Account